Search...
SA Quant ranks Goldman's health care stocks with biggest increase in hedge fund popularity
I'm PortAI, I can summarize articles.
Goldman Sachs analysts report a shift in hedge fund investments from consumer discretionary to health care stocks, particularly biotech, in Q3 2025. Vertex Pharmaceuticals, Bristol Myers Squibb, and Ocular Therapeutix are top picks with strong Seeking Alpha Quant ratings. The ratings system evaluates stocks on valuation, growth, profitability, and momentum, with ratings above 3.5 considered bullish.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments